ZURICH
(Reuters) - Swiss drugmaker Roche (ROG.S) reiterated on Tuesday that it
expects to achieve its full-year targets after sales during the first
three months of 2016 rose 4 percent, beating analyst expectations.
The
Basel-based company expects sales to grow in the low- to
mid-single-digit percentages at constant exchange rates, with faster
growth of core earnings per share. It plans to boost its dividend in
Swiss francs.
In
a statement, Roche said first-quarter sales rose to 12.4 billion Swiss
francs (8.9 billion pounds) compared to the 12.3 billion francs forecast
by analysts in a Reuters poll.
(Reporting by John Miller)
Reuters
No comments:
Post a Comment